BUY Aurobindo Pharma — Ansh Jogendra Bhilwar
byAnsh Jogendra BhilwarHorizon: Intraday28 Oct 2026, 8:00 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
1 advisor has an active swing SELL call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·21 Oct · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aurobindo Pharma
- SELL — Sahaj Agrawal, Kotak Securities21 Oct 2026 · ~2 weeks · target ₹1,540 · Active
- BUY — Arun Kumar Mantri12 Oct 2026 · ~2 weeks · target ₹1,745 · SL hit
- BUY — Ajit Mishra, Religare12 Oct 2026 · ~2 weeks · target ₹1,820 · SL hit
- BUY — Manas Jaiswal12 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Rupak De, LKP Securities9 Oct 2026 · ~2 weeks · target ₹1,800 · SL hit
More from Ansh Jogendra Bhilwar
- BUY Samvardhana Motherson International28 Oct 2026 · Same day · target ₹162 · Expired
- BUY Trent28 Oct 2026 · Same day · target ₹2,890 · Target hit
- BUY Max Financial Services28 Oct 2026 · Same day · target ₹1,265 · SL hit
- BUY Laurus Labs28 Oct 2026 · ~1 year · target ₹2,415 · Active
- BUY Tanla Platforms28 Oct 2026 · ~3 months · target ₹640 · Active

